Lymph node status as a prognostic indicator after preoperative neoadjuvant chemoradiotherapy of rectal cancer

Colorectal Disease

Volumn 16, Issue 10, 2014, Pages O339-O346

  Mirbagheri, Naseem ^a   Kumar, B ^b   Deb, S ^c   Poh, B R ^a   Dark, J G ^d   Leow, C C ^a   Teoh, W M K ^a  

^a DANDENONG HOSPITAL   (Australia)

^b MONASH MEDICAL CENTRE   (Australia)

^c PETER MACCALLUM CANCER CENTRE   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Chemoradiotherapy; Lymph nodes; Neoadjuvant therapy; Rectal neoplasms

Indexed keywords

FLUOROURACIL;

ADJUVANT CHEMORADIOTHERAPY; ADULT; ARTICLE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURGERY; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONFIDENCE INTERVAL; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; DISTANT METASTASIS; FEMALE; FIBROSIS; FOLLOW UP; HAZARD RATIO; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LOCAL METASTASIS; LYMPH NODE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREOPERATIVE TREATMENT; PROPORTIONAL HAZARDS MODEL; RECTUM CANCER; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; SCORING SYSTEM; SURVIVAL RATE; TUMOR VOLUME; ADJUVANT THERAPY; AGED; CANCER STAGING; MIDDLE AGED; PATHOLOGY; RECTAL NEOPLASMS; REMISSION; TUMOR RECURRENCE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CHEMORADIOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; FEMALE; FIBROSIS; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RECTAL NEOPLASMS; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84908461754     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/codi.12682     Document Type: Article

References (11)

1. Habr-Gama A. Non-operative management of rectal cancer after neoadjuvant chemoradiation. Br J Surg 2009; 96:125-7.
2. Kosinski L, Habr-Gama A, Ludwig K, Perez R. Shifting concepts in rectal cancer management: a review of contemporary primary rectal cancer treatment strategies. CA Cancer J Clin 2012; 62: 173-202.
3. Kahn H, Alexander A, Rakinic J, Nagle D, Fry R. Preoperative staging of irradiated rectal cancers using digital rectal examination, computed tomography, endorectal ultrasound, and magnetic resonance imaging does not accurately predict T0, N0 pathology. Dis Colon Rectum 1997; 40: 140-4.
4. Mandard AM, Dalibard F, Mandard JC, Marnay J. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer 1994; 73: 2680-6.
5. Caricato M, De Dominicis E, Vincenzi B, Rabitti C. Tumor regression in mesorectal lymphnodes after neoadjuvant chemoradiation for rectal cancer. Eur J Surg Oncol 2007; 33: 724-8.
6. Nathanson SD. Insights into the mechanisms of lymph node metastasis. Cancer 2003; 98: 413-23.
7. Jang TY, Yu CS, Yoon YS et al. Oncologic outcome after preoperative chemoradiotherapy in patients with pathologic T0 (ypT0) rectal cancer. Dis Colon Rectum 2012; 55:1024-31.
8. Yeo S-G, Kim DY, Kim TH et al. Pathologic complete response of primary tumor following preoperative chemoradiotherapy for locally advanced rectal cancer. Ann Surg 2010; 252: 998-1004.
9. Lindebjerg J, Spindler KLG, Ploen J, Jakobsen A. The prognostic value of lymph node metastases and tumour regression grade in rectal cancer patients treated with long-course preoperative chemoradiotherapy. Colorectal Dis 2009; 11: 264-9.
10. Habr-Gama A, Perez RO, Proscurshim I et al. Absence of lymph nodes in the resected specimen after radical surgery for distal rectal cancer and neoadjuvant chemoradiation therapy: what does it mean? Dis Colon Rectum 2008; 51:277-83.
11. Read TE, Andujar JE, Caushaj PF et al. Neoadjuvant therapy for rectal cancer: histologic response of the primary tumor predicts nodal status. Dis Colon Rectum 2004; 47:825-31.